112 related articles for article (PubMed ID: 19994512)
21. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model.
Vergote I; Larsen RH; de Vos L; Nesland JM; Bruland O; Bjørgum J; Alstad J; Tropé C; Nustad K
Gynecol Oncol; 1992 Dec; 47(3):366-72. PubMed ID: 1473751
[TBL] [Abstract][Full Text] [Related]
22. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
Goddu SM; Bishayee A; Bouchet LG; Bolch WE; Rao DV; Howell RW
J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
[TBL] [Abstract][Full Text] [Related]
23. Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution.
Bao A; Zhao X; Phillips WT; Woolley FR; Otto RA; Goins B; Hevezi JM
Med Phys; 2005 Jan; 32(1):200-8. PubMed ID: 15719971
[TBL] [Abstract][Full Text] [Related]
24. Dosimetry in Radiosynoviorthesis: 90Y VS. 153Sm.
Torres Berdeguez MB; Thomas S; Medeiros S; de Sá LV; Mas Milian F; da Silva AX
Health Phys; 2018 Jan; 114(1):1-6. PubMed ID: 28990969
[TBL] [Abstract][Full Text] [Related]
25. Internal irradiation for cystic craniopharyngioma.
Kobayashi T; Kageyama N; Ohara K
J Neurosurg; 1981 Dec; 55(6):896-903. PubMed ID: 6271932
[TBL] [Abstract][Full Text] [Related]
26. Targeted radionuclide therapy: theoretical study of the relationship between tumour control probability and tumour radius for a 32P/33P radionuclide cocktail.
Lechner A; Blaickner M; Gianolini S; Poljanc K; Aiginger H; Georg D
Phys Med Biol; 2008 Apr; 53(7):1961-74. PubMed ID: 18354241
[TBL] [Abstract][Full Text] [Related]
27. Monte carlo parametric study of stent impact on dose for catheter-based intravascular brachytherapy with 90Sr/90Y.
Ortego PM; Prieto C; Vano E
Med Phys; 2004 Jul; 31(7):1964-71. PubMed ID: 15305447
[TBL] [Abstract][Full Text] [Related]
28. 211At radiocolloid therapy: further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y.
Bloomer WD; McLaughlin WH; Lambrecht RM; Atcher RW; Mirzadeh S; Madara JL; Milius RA; Zalutsky MR; Adelstein SJ; Wolf AP
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):341-8. PubMed ID: 6706730
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo dose characterization of a new 90Sr/90Y source with balloon for intravascular brachytherapy.
Wang R; Li XA; Lobdell J
Med Phys; 2003 Jan; 30(1):27-33. PubMed ID: 12557975
[TBL] [Abstract][Full Text] [Related]
30. A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions.
Lanconelli N; Pacilio M; Lo Meo S; Botta F; Di Dia A; Aroche AT; Pérez MA; Cremonesi M
Phys Med Biol; 2012 Jan; 57(2):517-33. PubMed ID: 22217735
[TBL] [Abstract][Full Text] [Related]
31. [Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary beta-irradiation (Re-186; Au-198; Y-90)].
Musolino A; Munari C; Blond S; Betti O; Lajat Y; Schaub C; Askienazy S; Chodkiewicz JP
Neurochirurgie; 1985; 31(3):169-78. PubMed ID: 3897891
[TBL] [Abstract][Full Text] [Related]
32. The spatial and energy dependence of bremsstrahlung production about beta point sources in H2O.
Simpkin DJ; Cullom SJ; Mackie TR
Med Phys; 1992; 19(1):105-14. PubMed ID: 1620037
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
[TBL] [Abstract][Full Text] [Related]
34. Biologic dosimetry of bone marrow: induction of micronuclei in reticulocytes after exposure to 32P and 90Y.
Lenarczyk M; Goddu SM; Rao DV; Howell RW
J Nucl Med; 2001 Jan; 42(1):162-9. PubMed ID: 11197968
[TBL] [Abstract][Full Text] [Related]
35. Potential use of P-32 ophthalmic applicator: Monte Carlo simulations for design and dosimetry.
Park YK; Ye SJ; Kim IH; Wee WR; Kim MK; Han HS; Son KJ; Park UJ
Med Phys; 2008 May; 35(5):1854-8. PubMed ID: 18561660
[TBL] [Abstract][Full Text] [Related]
36. Monte Carlo calculated TG-60 dosimetry parameters for the beta- emitter 153Sm brachytherapy source.
Sadeghi M; Taghdiri F; Hosseini SH; Tenreiro C
Med Phys; 2010 Oct; 37(10):5370-5. PubMed ID: 21089772
[TBL] [Abstract][Full Text] [Related]
37. The dosimetry for a coronary artery stent coated with radioactive 188Re and 32P.
Fox RA; Henson PW
Phys Med Biol; 2000 Dec; 45(12):3643-55. PubMed ID: 11131190
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
Sharkey RM; Brenner A; Burton J; Hajjar G; Toder SP; Alavi A; Matthies A; Tsai DE; Schuster SJ; Stadtmauer EA; Czuczman MS; Lamonica D; Kraeber-Bodere F; Mahe B; Chatal JF; Rogatko A; Mardirrosian G; Goldenberg DM
J Nucl Med; 2003 Dec; 44(12):2000-18. PubMed ID: 14660727
[TBL] [Abstract][Full Text] [Related]
39. The application of dose-rate volume histograms and survival fractions to multicellular dosimetry.
Malaroda A; Flux G; Ott R
Cancer Biother Radiopharm; 2005 Feb; 20(1):58-65. PubMed ID: 15778582
[TBL] [Abstract][Full Text] [Related]
40. The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas.
Schefter JK; Allen G; Cmelak AJ; Johnson M; Toms S; Duggan D; Blevins LS
J Neurooncol; 2002 Jan; 56(1):69-78. PubMed ID: 11949829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
